Impact of prior use of antiplatelet agents and non-vitamin K antagonist oral anticoagulants on stroke outcomes among endovascular-treated patients with high pre-stroke CHA2DS2-VASc score

MLA

Kim, Chulho, et al. “Impact of Prior Use of Antiplatelet Agents and Non-Vitamin K Antagonist Oral Anticoagulants on Stroke Outcomes among Endovascular-Treated Patients with High Pre-Stroke CHA2DS2-VASc Score.” Journal of Neurointerventional Surgery, vol. 16, no. 10, Jan. 2024, pp. 1053–59. EBSCOhost, https://doi.org/10.1136/jnis-2023-020698.

APA

Kim, C., Sohn, J.-H., Lee, M., Kim, Y., Mo, H. J., Oh, M. S., Yu, K.-H., & Lee, S.-H. (2024). Impact of prior use of antiplatelet agents and non-vitamin K antagonist oral anticoagulants on stroke outcomes among endovascular-treated patients with high pre-stroke CHA2DS2-VASc score. Journal of Neurointerventional Surgery, 16(10), 1053–1059. https://doi.org/10.1136/jnis-2023-020698

Chicago

Kim, Chulho, Jong-Hee Sohn, Minwoo Lee, Yerim Kim, Hee Jung Mo, Mi Sun Oh, Kyung-Ho Yu, and Sang-Hwa Lee. 2024. “Impact of Prior Use of Antiplatelet Agents and Non-Vitamin K Antagonist Oral Anticoagulants on Stroke Outcomes among Endovascular-Treated Patients with High Pre-Stroke CHA2DS2-VASc Score.” Journal of Neurointerventional Surgery 16 (10): 1053–59. doi:10.1136/jnis-2023-020698.